Methodological issues in pharmacokinetic-pharmacodynamic modelling

被引:41
|
作者
Bellissant, E
Sébille, V
Paintaud, G
机构
[1] Fac Med, Lab Pharmacol Expt & Clin, F-35043 Rennes, France
[2] Hop Brettoneau, Lab Pharmacol & Toxicol, Tours, France
关键词
D O I
10.2165/00003088-199835020-00004
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
This article presents the theoretical and practical aspects involved in the design and analysis of pharmacokinetic-pharmacodynamic modelling studies. The main features of the protocol of pharmacokinetic-pharmacodynamic studies are discussed with special focus on experimental designs in relation to individual and population approaches. Some basic pharmacodynamic models (such as linear, log-linear, hyperbolic and sigmoid models) are presented as well as more complex time-dependent models (effect compartment and physiological indirect response, tolerance models) which are required when the concentration-effect relationship shows a hysteresis loop. The methods of estimation, with special focus on the individual and populations approaches, are covered, along with the way pharmacodynamic models and methods of estimation can be applied to real data and the information required to criticise the results of modelling. We also present some real problems frequently encountered when performing pharmacokinetic-pharmacodynamic modelling and give some potential solutions (problems with hysteresis loops, lack of convergence, problems with residuals). The last section discusses the significance of pharmacodynamic parameters.
引用
收藏
页码:151 / 166
页数:16
相关论文
共 50 条
  • [21] Pharmacokinetic-pharmacodynamic modelling of cisplatin renal toxicity in cancer patients
    Guillermet, A.
    Bourguignon, L.
    Goutelle, S.
    Tredan, O.
    Favier, B.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2010, 24 : 58 - 58
  • [22] Pharmacokinetic-Pharmacodynamic Modelling of Biomarker Response to Sitagliptin in Healthy Volunteers
    Kim, Bo-Hyung
    Kim, Sung Eun
    Kang, Dongwoo
    Lim, Kyoung Soo
    Kim, Jung-Ryul
    Jang, In-Jin
    Shin, Sang-Goo
    Yoon, Seo Hyun
    Cho, Joo-Youn
    Yu, Kyung-Sang
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2013, 113 (02) : 113 - 125
  • [23] Impact of pharmacokinetic-pharmacodynamic modelling in early clinical drug development
    Dingemanse, Jasper
    Krause, Andreas
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2017, 109 : S53 - S58
  • [24] Pharmacokinetic-pharmacodynamic modeling:: Why?
    Pérez-Urizar, J
    Granados-Soto, V
    Flores-Murrieta, FJ
    Castañeda-Hernández, G
    ARCHIVES OF MEDICAL RESEARCH, 2000, 31 (06) : 539 - 545
  • [25] Pharmacokinetic-pharmacodynamic relationships for analgesics
    Suri, A
    Estes, KS
    Geisslinger, G
    Derendorf, H
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 1997, 35 (08) : 307 - 323
  • [26] Pharmacokinetic-pharmacodynamic modeling of opioids
    Lötsch, JR
    JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2005, 29 (05) : S90 - S103
  • [27] Methodological features of clinical pharmacokinetic-pharmacodynamic studies of antibacterials and antifungals: a systematic review
    McAleenan, Alexandra
    Ambrose, Paul G.
    Bhavnani, Sujata M.
    Drusano, George L.
    Hope, William W.
    Mouton, Johan W.
    Higgins, Julian P. T.
    MacGowan, Alasdair P.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2020, 75 (06) : 1374 - 1389
  • [28] Pharmacokinetic-pharmacodynamic relationships for benzodiazepines
    Laurijssens, BE
    Greenblatt, DJ
    CLINICAL PHARMACOKINETICS, 1996, 30 (01) : 52 - 76
  • [29] Pharmacokinetic-pharmacodynamic correlations in psychopharmacology
    Danhof, M.
    BEHAVIOURAL PHARMACOLOGY, 2007, 18 : S112 - S113
  • [30] Microdialysis for pharmacokinetic-pharmacodynamic studies
    Yu, W.
    Cheng, Q.
    Feng, J.
    Li, F.
    PHARMAZIE, 2007, 62 (12): : 883 - 891